<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Lipid Res</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Lipid Res</journal-id>
<journal-id journal-id-type="hwp">jlr</journal-id>
<journal-id journal-id-type="pmc">jlr</journal-id>
<journal-id journal-id-type="publisher-id">jlr</journal-id>
<journal-title-group>
<journal-title>Journal of Lipid Research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-2275</issn>
<issn pub-type="epub">1539-7262</issn>
<publisher>
<publisher-name>The American Society for Biochemistry and Molecular Biology</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">25926691</article-id>
<article-id pub-id-type="pmc">4655994</article-id>
<article-id pub-id-type="publisher-id">r059220</article-id>
<article-id pub-id-type="doi">10.1194/jlr.R059220</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Thematic Review Series</subject>
</subj-group>
<series-title>Thematic Review Series: Phospholipases: Central Role in Lipid Signaling and Disease</series-title>
</article-categories>
<title-group>
<article-title>Physiological and pathophysiological roles for phospholipase D</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Nelson</surname>
<given-names>Rochelle K.</given-names>
</name>
<xref ref-type="aff" rid="aff1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Frohman</surname>
<given-names>Michael A.</given-names>
</name>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">†</xref>
</contrib>
<aff id="aff1">Graduate Program in Physiology and Biophysics<label>*</label><institution>Stony Brook University</institution>, Stony Brook, NY</aff>
<aff id="aff2">Department of Pharmacological Sciences, <label>†</label><institution>Stony Brook University</institution>, Stony Brook, NY</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>1</label>To whom correspondence should be addressed. e-mail: <email>Michael.Frohman@stonybrook.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>12</month>
<year>2015</year>
</pub-date>
<!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
<pub-date pub-type="ppub">
<month>12</month>
<year>2015</year>
</pub-date>
<volume>56</volume>
<issue>12</issue>
<fpage>2229</fpage>
<lpage>2237</lpage>
<history>
<date date-type="received">
<day>13</day>
<month>3</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>28</day>
<month>4</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2015 by the American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement>
<copyright-year>2015</copyright-year>
</permissions>
<abstract>
<p>Individual members of the mammalian phospholipase D (PLD) superfamily undertake roles that extend from generating the second messenger signaling lipid, phosphatidic acid, through hydrolysis of the membrane phospholipid, phosphatidylcholine, to functioning as an endonuclease to generate small RNAs and facilitating membrane vesicle trafficking through seemingly nonenzymatic mechanisms. With recent advances in genome-wide association studies, RNA interference screens, next-generation sequencing approaches, and phenotypic analyses of knockout mice, roles for PLD family members are being uncovered in autoimmune, infectious neurodegenerative, and cardiovascular disease, as well as in cancer. Some of these disease settings pose opportunities for small molecule inhibitory therapeutics, which are currently in development.</p>
</abstract>
<kwd-group>
<kwd>lipid signaling</kwd>
<kwd>phosphatidic acid</kwd>
<kwd>cancer</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>